| Particulars |
|
|
|
| Company Name
| Gland Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
16.48 |
B.V. (₹) |
592.10 |
| Sales(₹ Cr.) |
4,116.15 |
NP (₹ Cr.) |
1,089.75 |
| NP Var% |
4.00 |
Div% |
1,800.00 |
| CPS(₹) |
76.40 |
EPS (₹) |
66.10 |
| Traded Value(₹ Lakhs) |
131.98 |
52 Week High |
2,221.00 |
| 52 Week Low |
1,200.00 |
Price BSE |
1,877.00 |
| Price NSE |
1,878.00 |
Market Capital (₹ Cr.) |
30,919.84 |
| P/C Ratio |
24.60 |
P/E Ratio |
28.40 |
| Price Vs.BV |
3.17 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
1,030.35 |
| NP(₹ Cr.) |
290.00 |
NP Var % |
-10.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
4,347.71 |
| OPM |
33.57 |
NP |
1,102.85 |
| NP Var% |
4.41 |
EPS |
66.14 |
| PE |
28.37 |
|
|